Entity

Colorectal Cancer

Cancer of the colon or rectum — among the most common cancers worldwide and a major focus of screening and drug development.

As of 10 Oct 2026Last evidence 10 Oct 2026

What is happening now

  • FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer

    Reported claim · first reported 8 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

  • Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer.

    Reported claim · first reported 6 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

All 2 events and claims involving Colorectal Cancer

What changed

  • Attention Rising: 60 mentions on 10 Oct 2026, against 82 on 19 Sept 2026 (-27%).
  • State Changes between snapshots: cannot measure, no state history is kept for Colorectal Cancer yet.
  • Claims No claim first reported since 9 Oct 2026.

How well we know this

1,734 documents · 391 publishers · 9% contain a typed assertion · last evidence 10 Oct 2026

  • Gap: assertion coverage 0.085: about 92% of mentions carry no typed assertion

In this snapshot’s daily coverage:

Reported alongside Colorectal Cancer

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

ImmunotherapyKRASBrafAIMSI-H
  • Immunotherapy · 267 shared documents
  • KRAS · 135 shared documents
  • ctDNA · 125 shared documents · no page of its own yet
  • Braf · 87 shared documents
  • AI · 86 shared documents
  • Egfr · 71 shared documents · no page of its own yet
  • Wang · 69 shared documents · no page of its own yet
  • MSI-H · 68 shared documents
  • Zhang · 63 shared documents · no page of its own yet
  • Lung Cancer · 60 shared documents · no page of its own yet

Story momentum

Rising

Daily mentions +15% from 28 Aug 2026 to 10 Oct 2026, between 35 and 172 a day

How often tracked coverage mentions Colorectal Cancer, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about Colorectal Cancer yet. Ask about Colorectal Cancer

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/e65e9524bedac8b311cd8e6e returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name colorectal cancer.

{
  "name": "colorectal cancer",
  "label": "Colorectal Cancer",
  "asOf": "2026-10-10",
  "mentions": 190,
  "outlets": 125,
  "domains": 10,
  "node": {
    "id": "sb:e/e65e9524bedac8b311cd8e6e",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/e65e9524bedac8b311cd8e6e",
    "knowledgeCutoff": "2026-10-10T20:32:23.797512+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "rising",
  "whereFrom": {
    "level": "counts",
    "label": "190 mentions across 10 domains",
    "children": [
      {
        "level": "reports",
        "label": "6 reports drawn on this page, each with its link",
        "children": {
          "count": 6,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "10 coverage domains",
        "children": {
          "count": 10,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 184 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving Colorectal Cancer

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

  • FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer

    Reported claim · first reported 8 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

    corroborated

  • Integrated spatial and single-cell transcriptomics uncover IFI6⁺ regulatory T-cells and SPP1⁺ macrophages immunosuppressive niches in colorectal cancer.

    Reported claim · first reported 6 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    single source

Walk the record from Colorectal Cancer

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

Colorectal Cancer

Entity.

Evidence
1,734 documents · 391 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 1 Jan 2026, last seen 10 Oct 2026
Measured
9% of mentions say something specific about it; the rest only name it
As of
10 Oct 2026
12 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (2)

  • Corroborated: Reported by three or more sources that did not copy each other.
  • Reported by two: Reported by two sources that did not copy each other.

Situations it is named in (0)

none on file at this cutoff

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names Colorectal Cancer, newest first. Open any row to follow it to the original article.

What it connects to

Related records.

Ask about Colorectal CancerWatch Colorectal Cancer

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 10 Oct 2026.